These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1942267)

  • 1. What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma.
    Herrlinger A; Schrott KM; Schott G; Sigel A
    J Urol; 1991 Nov; 146(5):1224-7. PubMed ID: 1942267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy.
    Schafhauser W; Ebert A; Brod J; Petsch S; Schrott KM
    Anticancer Res; 1999; 19(2C):1573-8. PubMed ID: 10365148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical nephrectomy for renal cell carcinoma: long-term results and prognostic factors on a series of 328 cases.
    Giberti C; Oneto F; Martorana G; Rovida S; Carmignani G
    Eur Urol; 1997; 31(1):40-8. PubMed ID: 9032533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the benefit of systematic regional lymph node dissection in tumor nephrectomy?].
    Herrlinger A; Kühn R; Sigel A
    Helv Chir Acta; 1990 Nov; 57(3):477-81. PubMed ID: 2269635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Method of radical transabdominal tumor nephrectomy with facultative or systemic lymph node dissection and results in 381 patients].
    Herrlinger A; Sigel A; Giedl J
    Urologe A; 1984 Sep; 23(5):267-74. PubMed ID: 6390923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
    Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
    J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
    Blute ML; Leibovich BC; Cheville JC; Lohse CM; Zincke H
    J Urol; 2004 Aug; 172(2):465-9. PubMed ID: 15247704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improved actuarial results in the treatment of kidney cancer by systematic lymph node excision].
    De Bruyn W; Herrlinger A; Sigel A
    J Urol (Paris); 1989; 95(3):133-7. PubMed ID: 2745994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
    Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
    BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.
    Capitanio U; Matloob R; Suardi N; Abdollah F; Castiglione F; Di Trapani D; Russo A; Briganti A; Carenzi C; Salonia A; Montorsi F; Rigatti P; Bertini R
    Urologia; 2012; 79(2):109-15. PubMed ID: 22610843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal lymph nodes for tumor staging: appraisal of 871 nephrectomies with examination of hilar fat.
    Mehta V; Mudaliar K; Ghai R; Quek ML; Milner J; Flanigan RC; Picken MM
    Arch Pathol Lab Med; 2013 Nov; 137(11):1584-90. PubMed ID: 23651149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of radical nephrectomy associated with regional lymphadenectomy for renal cell carcinoma].
    Igarashi T; Murakami S; Hara S; Tanaka M; Oki T; Isaka S; Okano T; Abe K; Shimazaki J; Matsuzaki O
    Hinyokika Kiyo; 1991 Sep; 37(9):975-80. PubMed ID: 1785423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of lymphadenectomy in renal cell carcinoma.
    Ditonno P; Traficante A; Battaglia M; Grossi FS; Selvaggi FP
    Prog Clin Biol Res; 1992; 378():169-74. PubMed ID: 1301578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience.
    Bazzi WM; Sjoberg DD; Feuerstein MA; Maschino A; Verma S; Bernstein M; O'Brien MF; Jang T; Lowrance W; Motzer RJ; Russo P
    J Urol; 2015 Jun; 193(6):1911-6. PubMed ID: 25524244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
    Gershman B; Thompson RH; Boorjian SA; Larcher A; Capitanio U; Montorsi F; Carenzi C; Bertini R; Briganti A; Lohse CM; Cheville JC; Leibovich BC
    J Urol; 2018 May; 199(5):1143-1148. PubMed ID: 29225056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphatic metastases in renal cell carcinoma. What is the value of operation and adjuvant therapy?].
    Mickisch GH
    Urologe A; 1999 Jul; 38(4):326-31. PubMed ID: 10444789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.